The PE Ratio as of March 2026 (TTM) for Oruka Therapeutics, Inc. (ORKA) is -22.48

According to Oruka Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -22.48. This represents a change of 191.53% compared to the average of -7.71 of the last 4 quarters.

Oruka Therapeutics, Inc. (ORKA) Historical PE Ratio (quarterly & annually)

How has ORKA PE Ratio performed in the past?

The mean historical PE Ratio of Oruka Therapeutics, Inc. over the last ten years is -15.95. The current -22.48 PE Ratio has changed 13.99% with respect to the historical average. Over the past ten years (40 quarters), ORKA's PE Ratio was at its highest in in the March 2018 quarter at -0.62. The PE Ratio was at its lowest in in the December 2023 quarter at -67.51.

Oruka Therapeutics, Inc. (ORKA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oruka Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oruka Therapeutics, Inc. (ORKA) Average PE Ratio

How has ORKA PE Ratio performed in the past?

The current PE Ratio of Oruka Therapeutics, Inc. (ORKA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Oruka Therapeutics, Inc. (ORKA) PE Ratio vs. Peers

How is ORKA’s PE Ratio compared to its peers?

Oruka Therapeutics, Inc.’s PE Ratio is less than Phathom Pharmaceuticals, Inc. (-3.41), less than BridgeBio Oncology Therapeutics Inc. (-2.14), less than Rapport Therapeutics, Inc. Common Stock (-11.94), less than Kodiak Sciences Inc. (-5.79), less than Xencor, Inc. (-9.91), less than Nurix Therapeutics, Inc. (-5.55), greater than AnaptysBio, Inc. (-137.84), less than UroGen Pharma Ltd. (-6.02), less than Oculis Holding AG (-11.65), less than Mind Medicine (MindMed) Inc. (-8.94),

Build a custom stock screener for Oruka Therapeutics, Inc. (ORKA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oruka Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oruka Therapeutics, Inc. (ORKA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oruka Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.